Plandai Biotechnology (PK) Stock Quote PLPL - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.0001

Bid

0.0001

Ask

0.0002

Volume

4,500,200

0.0001 Day's Range 0.0002

0.000098 52 Week Range 0.0007

Market Cap

10.142k

Previous Close

0.0002

Open

0.0002

Last Trade

2000000

0.0001

Last Trade Time

Financial Volume

$ 650

VWAP

0.000144

Average Volume (3m)

70,670,350

Shares Outstanding

101,415,300

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

-0.2

Revenue

Net Profit

-19.8M

Plandai Biotechnology, Inc., a Nevada corporation, is a publicly quoted shell company seeking to create value for its shareholders by merging with another entity with experienced management and opportunities for growth. No potential merger candidate has been identified at this time. Plandai Biotechnology, Inc., a Nevada corporation, is a publicly quoted shell company seeking to create value for its shareholders by merging with another entity with experienced management and opportunities for growth. No potential merger candidate has been identified at this time.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Las Vegas, Nevada, USA

Founded

1970

Plandai Biotechnology Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PLPL. The last closing price for Plandai Biotechnology (PK) was $0. Over the last year, Plandai Biotechnology (PK) shares have traded in a share price range of $ 0.000098 to $ 0.0007.

Plandai Biotechnology (PK) currently has 101,415,300 shares outstanding. The market capitalization of Plandai Biotechnology (PK) is $20,283.06 . Plandai Biotechnology (PK) has a price to earnings ratio (PE ratio) of 0.00.

FeaturedPOET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks

Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes

Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes NEW YORK, NY-(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL...

Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules

Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules NEW YORK, NY - Plandaí Biotechnology's (OTCQB: PLPL) Origine 8™ capsules could be the...

Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales

Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales NEW YORK, NY-(Marketwired - May 04, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced last week that its...

Plandai Biotechnology Gains Credibility with NutriBullet Deal

SOURCE: Plandai Biotechnology, Inc. April 26, 2017 09:00 ET Plandai Biotechnology Gains Credibility with NutriBullet Deal NEW YORK, NY-(Marketwired - April 26, 2017) - Plandaí Biotechnology...

Plandai Biotechnology Sets Aggressive Agenda for 2017

NEW YORK, NY-(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a number of milestones that the company plans to...

Plandai Biotechnology Announces Share Exchange Between Protext Mobility and Plandai's South Africa Subsidiary

Plandai South Africa Will Operate Independent From Plandai Parent and Focus on Pharmaceutical Application Research BOCA RATON, FL--(NewMediaWire - Jan...

OTC Stocks Daily Trading Focus: Neutra Corporation, Terra Tech Corp, Plandai Biotechnology, Inc. Nano Tech Entertainment, Inc...

OTC Stocks Daily Trading Focus: Neutra Corporation, Terra Tech Corp, Plandai Biotechnology, Inc. Nano Tech Entertainment, Inc. Techprecision Corp. PR Newswire LONDON, July 3, 2014 LONDON, July 3...

FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product

FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product NEW YORK, NY--(Marketwired - Jun 26, 2014) - Plandaí...

Plandai Biotechnology, Inc. Announces Phytofare(TM) Catechin Complex Shows Over Two Times the Level of Catechins Compared to ...

Plandai Biotechnology, Inc. Announces Phytofare(TM) Catechin Complex Shows Over Two Times the Level of Catechins Compared to Generic Extract Test Results Help Validate Plandai's Extraction...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0001	-50	0.0002	0.0002	0.0001	7706150	0.00013371	CS
4	-0.0001	-50	0.0002	0.0003	0.0001	35929348	0.00020121	CS
12	-0.0003	-75	0.0004	0.0007	0.0001	70670350	0.00040213	CS
26	-0.0001	-50	0.0002	0.0007	0.0001	67280361	0.00042039	CS
52	-0.0003	-75	0.0004	0.0007	9.8E-5	44008411	0.00037275	CS
156	-0.0005	-83.3333333333	0.0006	0.0021	9.8E-5	66834109	0.00072525	CS
260	-0.00065	-86.6666666667	0.00075	0.0036	9.8E-5	61412568	0.00079751	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTTTFCatena AB (PK)	$ 51.415 (73,350.00%)	230
AMHGQAmergent Hospitality Group Inc (CE)	$ 0.03 (29,900.00%)	22.66k
MKDTYMolecular Data Inc (CE)	$ 0.0001 (9,900.00%)	1.9k
HLLPFHello Pal International Inc (CE)	$ 0.01 (9,900.00%)	15.72k
AMOSFAtomos Ltd (CE)	$ 0.01 (9,900.00%)	14.2k
TWERTowerstream Corporation (CE)	$ 0.000001 (-100.00%)	127
RBMTFRambler Metals and Mining Public Limited Company (CE)	$ 0.000001 (-100.00%)	4k
MLBEF5G Networks Ltd (PK)	$ 0.0001 (-99.92%)	10.1k
NSEONS8 Corp (CE)	$ 0.000001 (-99.83%)	1,000
BLIAQBB Liquidating Inc (CE)	$ 0.0001 (-99.00%)	25.67k
GMPRGourmet Provisions International Corporation (PK)	$ 0.0001 (0.00%)	1.03B
HMBLHUMBL Inc (PK)	$ 0.0002 (-20.00%)	367.29M
ASIIAccredited Solutions Inc (PK)	$ 0.0002 (-33.33%)	296.74M
IDVVInternational Endeavors Corporation (PK)	$ 0.0009 (28.57%)	154.7M
SIRCSolar Integrated Roofing Corporation (PK)	$ 0.0001 (0.00%)	128.58M